Nuciferine’s dual pathway regulation of lipid metabolism: A biomechanical perspective based on HepG2 cells and Caenorhabditis elegans
Abstract
The lipid-lowering properties of lotus leaf are primarily attributed to the active alkaloid, nuciferine. In this study, the role and underlying mechanisms of nuciferine in lipid metabolism regulation from a biomechanical perspective were investigated using molecular docking and in vitro and in vivo studies, employing HepG2 cells and Caenorhabditis elegans (C. elegans) as experimental models. The results indicated that nuciferine exhibited significant binding affinity to the targets Sterol Regulatory Element-Binding Protein-1c (SREBP-1c) and Peroxisome Proliferator-Activated Receptor alpha (PPARα), suggesting that it may modulate lipid metabolism via the SREBP-1c/PPARα pathway. In vitro experiments demonstrated that nuciferine significantly inhibited the oleic acid-induced accumulation of triglycerides (TG) and total cholesterol (TC) in HepG2 cells. Furthermore, atomic force microscopy (AFM) was employed to detect the changes in cell elasticity and adhesion force before and after nuciferine treatment. We hypothesized that the lipid-lowering effect of nuciferine might be related to the alterations in the mechanical properties of cells, which could further influence lipid metabolism pathways. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis revealed that nuciferine could regulate the expression of SREBP-1c and PPARα, as well as their downstream target genes, which further affects the biomechanical properties of cells. In vivo experiments showed that nuciferine effectively attenuated hepatic steatosis and reduced TG levels in C. elegans, while modulating the expression of Sterol regulatory element-binding protein-1 (sbp-1), Nuclear hormone receptor 49 (nhr-49), and their downstream target genes. These changes may affect lipid metabolism through intercellular mechanical signaling. Furthermore, using mutant strains defective in sbp-1, nhr-49, fatty acid and triglyceride synthase 5 (fat-5); fat mass and obesity associated-like 6 (fat-6), and fat-6; fat mass and obesity associated-like 7 (fat-7) genes, the study provided further evidence that nuciferine’s lipid-lowering effects are mediated through the sbp-1/nhr-49 pathway. This study is the first to employ molecular docking to identify SREBP-1c and PPARα as the lipid-lowering targets of nuciferine and to confirm through in vitro and in vivo experiments that its efficacy depends on the SREBP-1c/sbp-1 and PPARα/nhr-49 pathways, thereby offering a new perspective for the treatment of lipid metabolic disorders from a biomechanical perspective.
References
1. Islam MdS, Wei P, Suzauddula M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine. 2024; 30(1). doi: 10.1186/s10020-024-01019-y
2. Min CY, Gao Y, Li Y, et al. The additional impact of metabolic syndrome on left ventricular deformation and myocardial energetic efficiency impairment in ischemia with nonobstructive coronary arteries patients. Cardiovascular Diabetology. 2025; 24(1). doi: 10.1186/s12933-025-02594-y
3. Sobukawa Y, Hatta T, Funaki D, et al. Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database. Drugs - Real World Outcomes. 2024; 11(2): 317-330. doi: 10.1007/s40801-024-00426-1
4. Silverman MG, Ference BA, Im K, et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions. JAMA. 2016; 316(12): 1289. doi: 10.1001/jama.2016.13985
5. Faluk M, Wardhere A, Mohamoud A, et al. Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future. Current Problems in Cardiology. 2024; 49(7): 102637. doi: 10.1016/j.cpcardiol.2024.102637
6. Ding Y, Pu L, Kan J. Hypolipidemic effects of lipid-lowering granulated tea preparation from Monascus-fermented grains (adlay and barley bran) mixed with lotus leaves on Sprague–Dawley rats fed a high-fat diet. Journal of Functional Foods. 2017; 32: 80-89. doi: 10.1016/j.jff.2017.02.025
7. Guo F, Yang X, Li X, et al. Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters. PLoS ONE. 2013; 8(5): e63770. doi: 10.1371/journal.pone.0063770
8. Kashiwada Y, et al. et al. anti‐HIV Benzylisoquinoline Alkaloids and Flavonoids from the Leaves of Nelumbo nucifera, and Structure—Activity Correlations with Related Alkaloids. ChemInform. 2005; 36(22). doi: 10.1002/chin.200522199
9. Hoa K, Nguyen N, Thi T, et al. Nuciferine Extracted from Sacred Lotus Stimulates Insulin Secretion in vitro Better than Glyburide. Canadian Journal of Diabetes. 2012.
10. Cui H, Li Y, Cao M, et al. Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats with Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 2020; 11. doi: 10.3389/fphar.2020.00858
11. Wang LM, Wang P, Teka T, et al. 1H NMR and UHPLC/Q-Orbitrap-MS-Based Metabolomics Combined with 16S rRNA Gut Microbiota Analysis Revealed the Potential Regulation Mechanism of Nuciferine in Hyperuricemia Rats. Journal of Agricultural and Food Chemistry. 2020; 68(47): 14059-14070. doi: 10.1021/acs.jafc.0c04985
12. Zhu G, Wu X, Wang Y, et al. A sensitive liquid chromatography-tandem mass spectrometry method for pharmacokinetics and tissue distribution of nuciferine in rats. Journal of chromatography, B Analytical technologies in the biomedical and life sciences. 2014.
13. Yao J, Hu P, Zhu Y, et al. Lipid-Lowering Effects of Lotus Leaf Alcoholic Extract on Serum, Hepatopancreas, and Muscle of Juvenile Grass Carp via Gene Expression. Frontiers in Physiology. 2020; 11. doi: 10.3389/fphys.2020.584782
14. Zhou Y, Chen Z, Lin Q, et al. Nuciferine reduced fat deposition by controlling triglyceride and cholesterol concentration in broiler chickens. Poultry Science. 2020; 99(12): 7101-7108. doi: 10.1016/j.psj.2020.09.013
15. Eberlé D, Hegarty B, Bossard P, et al. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004; 86(11): 839-848. doi: 10.1016/j.biochi.2004.09.018
16. Hu P, Li K, Peng X, et al. Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders. Nutrients. 2023; 15(22): 4772. doi: 10.3390/nu15224772
17. Sun Q, Xing X, Wang H, et al. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors. Biomedicine & Pharmacotherapy. 2024; 170: 115586. doi: 10.1016/j.biopha.2023.115586
18. Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD)—pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metabolism Reviews. 2017; 49(2): 197-211. doi: 10.1080/03602532.2017.1293683
19. Chu X, Zhou Y, Zhang S, et al. Chaetomorpha linum polysaccharides alleviate NAFLD in mice by enhancing the PPARα/CPT-1/MCAD signaling. Lipids in Health and Disease. 2022; 21(1). doi: 10.1186/s12944-022-01730-x
20. Wiriyakulsit N, Keawsomnuk P, Thongin S, et al. A model of hepatic steatosis with declined viability and function in a liver-organ-on-a-chip. Scientific Reports. 2023; 13(1).
21. Mosmann TJ. Rapid colorimetic assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods. 1983; 65(1-2): 53-63.
22. Toson EA, El-Fallal AA, Oransa MA, et al. In vitro antitumor effects of methanolic extracts of three Ganoderema mushrooms. Scientific Reports. 2025; 15(1). doi: 10.1038/s41598-025-86162-0
23. Dong X, Cai Y, Liao H, et al. Biological transformation of medicine and food homology hawthorn with Monascus ruber to enhance lipid-lowering function. Food Bioscience. 2024; 58: 103825. doi: 10.1016/j.fbio.2024.103825
24. Lee TH, Mun JY, Han SM, et al. DIC‐1 over‐expression enhances respiratory activity in Caenorhabditis elegans by promoting mitochondrial cristae formation. Genes to Cells. 2009; 14(3): 319-327. doi: 10.1111/j.1365-2443.2008.01276.x
25. Kang EJ, Lee SK, Park KK, et al. Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer‐Associated Bone Loss. Evidence-Based Complementary and Alternative Medicine. 2017; 2017(1). doi: 10.1155/2017/1583185
26. Zhang C, Deng J, Liu D, et al. Nuciferine ameliorates hepatic steatosis in high‐fat diet/streptozocin‐induced diabetic mice through a PPARα/PPARγ coactivator‐1α pathway. British Journal of Pharmacology. 2018; 175(22): 4218-4228. doi: 10.1111/bph.14482
27. Deng H, Xu Q, Sang XT, et al. Study on the vasodilatory activity of lotus leaf extract and its representative substance nuciferine on thoracic aorta in rats. Frontiers in Pharmacology. 2022; 13. doi: 10.3389/fphar.2022.946445
28. Xiao Y, Liu Z, Li P, et al. Lipid-lowering capacity of GABA-rich supernatant from fermented okara in OA-induced HepG2 cells. Food Bioscience. 2024; 58: 103659. doi: 10.1016/j.fbio.2024.103659
29. Tobore TO. Towards a comprehensive theory of obesity and a healthy diet: The causal role of oxidative stress in food addiction and obesity. Behavioural Brain Research. 2020; 384: 112560. doi: 10.1016/j.bbr.2020.112560
30. Zhang SO, Trimble R, Guo F, et al. Lipid droplets as ubiquitous fat storage organelles in C. elegans. BMC Cell Biology. 2010; 11(1). doi: 10.1186/1471-2121-11-96
31. Deutsch MJ, Schriever SC, Roscher AA, et al. Digital image analysis approach for lipid droplet size quantitation of Oil Red O-stained cultured cells. Analytical Biochemistry. 2014; 445: 87-89. doi: 10.1016/j.ab.2013.10.001
32. Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants. 2023; 12(2): 517. doi: 10.3390/antiox12020517
33. Hu Q, Liu Z, Guo Y, et al. Antioxidant capacity of flavonoids from Folium Artemisiae Argyi and the molecular mechanism in Caenorhabditis elegans. Journal of Ethnopharmacology. 2021; 279: 114398. doi: 10.1016/j.jep.2021.114398
34. Zhang M, Yang X, Xu W, et al. Evaluation of the effects of three sulfa sweeteners on the lifespan and intestinal fat deposition in C. elegans. Food Research International. 2019; 122: 66-76. doi: 10.1016/j.foodres.2019.03.028
35. Doi H, Hoshino Y, Nakase K, et al. Reduction of hydrogen peroxide stress derived from fatty acid beta-oxidation improves fatty acid utilization in Escherichia coli. Applied Microbiology and Biotechnology. 2013; 98(2): 629-639. doi: 10.1007/s00253-013-5327-6
36. An L, Fu X, Chen J, et al. Application of Caenorhabditis elegans in Lipid Metabolism Research. International Journal of Molecular Sciences. 2023; 24(2): 1173. doi: 10.3390/ijms24021173
37. Yang F, Vought BW, Satterlee JS, et al. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature. 2006; 442(7103): 700-704. doi: 10.1038/nature04942
38. Taubert S, Van Gilst MR, Hansen M, et al. A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. Genes & Development. 2006; 20(9): 1137-1149. doi: 10.1101/gad.1395406
Copyright (c) 2025 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.
Submit a Paper
